University of Southern California
USC Norris Comprehensive Cancer Center
If you are a patient, please contact Keck Medical Center of USC at 800-USC-CARE.

Publications for Norris Cancer Center Members in the Hematologic and Viral-Associated Malignancies Program

  • If you want to only view publications for one year, enter the 4 digit Year (e.g., 2001) and click Filter.
  • Authors who are Program members appear in bold.
  • Authors who are CC members from other programs are underlined.

Filter by Publication Year:From: To:

Total Number of Publications: 46 (At least 1 author in this program)
Inter Programmatic Publications: 37 (A collaboration outside the program...at least 1 author in the program, and at least 1 author out of the program)
Intra Programmatic Publications: 0 (A collaboration within the program...at least 2 authors in the program)

1: Kondo Y, Machida K, Liu HM, Ueno Y, Kobayashi K, Wakita T, Shimosegawa T, Lai MM
Hepatitis C virus infection of T cells inhibits proliferation and enhances fas-mediated apoptosis by down-regulating the expression of CD44 splicing variant 6.
J Infect Dis 199: 726-36 (2009)
PM ID: 19199548
2: Aparicio A, North B, Barske L, Wang X, Bollati V, Weisenberger D, Yoo C, Tannir N, Horne E, Groshen S, Jones P, Yang A, Issa JP
LINE-1 methylation in plasma DNA as a biomarker of activity of DNA methylation inhibitors in patients with solid tumors.
Epigenetics 4: 176-84 (2009)
PM ID: 19421002 PMC2848123 NIHMS184539
3: Liu HM, Aizaki H, Choi KS, Machida K, Ou JJ, Lai MM
SYNCRIP (synaptotagmin-binding, cytoplasmic RNA-interacting protein) is a host factor involved in hepatitis C virus RNA replication.
Virology 386: 249-56 (2009)
PM ID: 19232660 PMC3099193 NIHMS296131
4: Choi SH, Worswick S, Byun HM, Shear T, Soussa JC, Wolff EM, Douer D, Garcia-Manero G, Liang G, Yang AS
Changes in DNA methylation of tandem DNA repeats are different from interspersed repeats in cancer.
Int J Cancer 125: 723-9 (2009)
PM ID: 19437537 PMC4086885 NIHMS587075
5: Trageser D, Iacobucci I, Nahar R, Duy C, von Levetzow G, Klemm L, Park E, Schuh W, Gruber T, Herzog S, Kim YM, Hofmann WK, Li A, Storlazzi CT, Jäck HM, Groffen J, Martinelli G, Heisterkamp N, Jumaa H, Müschen M
Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function.
J Exp Med 206: 1739-53 (2009)
PM ID: 19620627 PMC2722172
6: Leonard RC, Williams S, Tulpule A, Levine AM, Oliveros S
Improving the therapeutic index of anthracycline chemotherapy: focus on liposomal doxorubicin (Myocet).
Breast 18: 218-24 (2009)
PM ID: 19656681
7: Klemm L, Duy C, Iacobucci I, Kuchen S, von Levetzow G, Feldhahn N, Henke N, Li Z, Hoffmann TK, Kim YM, Hofmann WK, Jumaa H, Groffen J, Heisterkamp N, Martinelli G, Lieber MR, Casellas R, Müschen M
The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia.
Cancer Cell 16: 232-45 (2009)
PM ID: 19732723 PMC2931825 NIHMS138671
8: Cozen W, Hamilton AS, Zhao P, Salam MT, Deapen DM, Nathwani BN, Weiss LM, Mack TM
A protective role for early oral exposures in the etiology of young adult Hodgkin lymphoma.
Blood 114: 4014-20 (2009)
PM ID: 19738032 PMC2774542
9: Byun HM, Siegmund KD, Pan F, Weisenberger DJ, Kanel G, Laird PW, Yang AS
Epigenetic profiling of somatic tissues from human autopsy specimens identifies tissue- and individual-specific DNA methylation patterns.
Hum Mol Genet 18: 4808-17 (2009)
PM ID: 19776032
10: Sumiyoshi T, Holt NG, Hollis RP, Ge S, Cannon PM, Crooks GM, Kohn DB
Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon system.
Hum Gene Ther 20: 1607-26 (2009)
PM ID: 19689196
11: Machida K, Liu JC, McNamara G, Levine A, Duan L, Lai MM
Hepatitis C virus causes uncoupling of mitotic checkpoint and chromosomal polyploidy through the Rb pathway.
J Virol 83: 12590-600 (2009)
PM ID: 19793824 PMC2786750
12: Nahar R, Müschen M
Pre-B cell receptor signaling in acute lymphoblastic leukemia.
Cell Cycle 8: 3874-7 (2009)
PM ID: 19901533 PMC4047560 NIHMS230959
13: Nowak D, Ogawa S, Müschen M, Kato M, Kawamata N, Meixel A, Nowak V, Kim HS, Kang S, Paquette R, Chang MS, Thoennissen NH, Thoenissen NH, Mossner M, Hofmann WK, Kohlmann A, Weiss T, Haferlach T, Haferlach C, Koeffler HP
SNP array analysis of tyrosine kinase inhibitor-resistant chronic myeloid leukemia identifies heterogeneous secondary genomic alterations.
Blood 115: 1049-53 (2010)
PM ID: 19965645 PMC2817631
14: Kantarjian HM, Erba HP, Claxton D, Arellano M, Lyons RM, Kovascovics T, Gabrilove J, Craig M, Douer D, Maris M, Petersdorf S, Shami PJ, Yeager AM, Eckert S, Abichandani R, Faderl S
Phase II study of clofarabine monotherapy in previously untreated older adults with acute myeloid leukemia and unfavorable prognostic factors.
J Clin Oncol 28: 549-55 (2010)
PM ID: 20026805
15: Wang XM, Greiner TC, Bibikova M, Pike BL, Siegmund KD, Sinha UK, Müschen M, Jaeger EB, Weisenburger DD, Chan WC, Shibata D, Fan JB, Hacia JG
Identification and functional relevance of de novo DNA methylation in cancerous B-cell populations.
J Cell Biochem 109: 818-27 (2010)
PM ID: 20069569 PMC3122883 NIHMS305118
16: Fei F, Stoddart S, Müschen M, Kim YM, Groffen J, Heisterkamp N
Development of resistance to dasatinib in Bcr/Abl-positive acute lymphoblastic leukemia.
Leukemia 24: 813-20 (2010)
PM ID: 20111071 PMC3038787 NIHMS164648
17: Wolff EM, Byun HM, Han HF, Sharma S, Nichols PW, Siegmund KD, Yang AS, Jones PA, Liang G
Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer.
PLoS Genet 6: e1000917 (2010)
PM ID: 20421991 PMC2858672
18: Müschen M
Genetic relicts from the origin of ALL.
Blood 115: 3424-5 (2010)
PM ID: 20430963
19: Duy C, Yu JJ, Nahar R, Swaminathan S, Kweon SM, Polo JM, Valls E, Klemm L, Shojaee S, Cerchietti L, Schuh W, Jäck HM, Hurtz C, Ramezani-Rad P, Herzog S, Jumaa H, Koeffler HP, de Alborán IM, Melnick AM, Ye BH, Müschen M
BCL6 is critical for the development of a diverse primary B cell repertoire.
J Exp Med 207: 1209-21 (2010)
PM ID: 20498019 PMC2882829
20: Parameswaran R, Müschen M, Kim YM, Groffen J, Heisterkamp N
A functional receptor for B-cell-activating factor is expressed on human acute lymphoblastic leukemias.
Cancer Res 70: 4346-56 (2010)
PM ID: 20460528 PMC2880197 NIHMS192821
21: Holt N, Wang J, Kim K, Friedman G, Wang X, Taupin V, Crooks GM, Kohn DB, Gregory PD, Holmes MC, Cannon PM
Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo.
Nat Biotechnol 28: 839-47 (2010)
PM ID: 20601939 PMC3080757 NIHMS216984
22: Chen YC, Su WC, Huang JY, Chao TC, Jeng KS, Machida K, Lai MM
Polo-like kinase 1 is involved in hepatitis C virus replication by hyperphosphorylating NS5A.
J Virol 84: 7983-93 (2010)
PM ID: 20534861 PMC2916529
23: Machida K, Tsukamoto H, Liu JC, Han YP, Govindarajan S, Lai MM, Akira S, Ou JH
c-Jun mediates hepatitis C virus hepatocarcinogenesis through signal transducer and activator of transcription 3 and nitric oxide-dependent impairment of oxidative DNA repair.
Hepatology 52: 480-92 (2010)
PM ID: 20683948 PMC3107125 NIHMS295838
24: Yun JP, Behan JW, Heisterkamp N, Butturini A, Klemm L, Ji L, Groffen J, Müschen M, Mittelman SD
Diet-induced obesity accelerates acute lymphoblastic leukemia progression in two murine models.
Cancer Prev Res (Phila) 3: 1259-64 (2010)
PM ID: 20823291 PMC2955776 NIHMS227757
25: Tallman M, Douer D, Gore S, Powell BL, Ravandi F, Rowe J, Ranganathan A, Sanz MA
Treatment of patients with acute promyelocytic leukemia: a consensus statement on risk-adapted approaches to therapy.
Clin Lymphoma Myeloma Leuk 10 Suppl 3: S122-6 (2010)
PM ID: 21115429
26: Gruber TA, Chang MS, Sposto R, Müschen M
Activation-induced cytidine deaminase accelerates clonal evolution in BCR-ABL1-driven B-cell lineage acute lymphoblastic leukemia.
Cancer Res 70: 7411-20 (2010)
PM ID: 20876806 PMC2948648 NIHMS228027
27: Bernstein I, Byun HM, Mohrbacher A, Douer D, Gorospe G, Hergesheimer J, Groshen S, O'Connell C, Yang AS
A phase I biological study of azacitidine (Vidaza™) to determine the optimal dose to inhibit DNA methylation.
Epigenetics 5: 750-7 (2010)
PM ID: 20861661
28: Fang C, Wang Y, Vu NT, Lin WY, Hsieh YT, Rubbi L, Phelps ME, Müschen M, Kim YM, Chatziioannou AF, Tseng HR, Graeber TG
Integrated microfluidic and imaging platform for a kinase activity radioassay to analyze minute patient cancer samples.
Cancer Res 70: 8299-308 (2010)
PM ID: 20837665 PMC3989903 NIHMS234510
29: Lai CK, Jeng KS, Machida K, Lai MM
Hepatitis C virus egress and release depend on endosomal trafficking of core protein.
J Virol 84: 11590-8 (2010)
PM ID: 20739534 PMC2953145
30: Machida K, McNamara G, Cheng KT, Huang J, Wang CH, Comai L, Ou JH, Lai MM
Hepatitis C virus inhibits DNA damage repair through reactive oxygen and nitrogen species and by interfering with the ATM-NBS1/Mre11/Rad50 DNA repair pathway in monocytes and hepatocytes.
J Immunol 185: 6985-98 (2010)
PM ID: 20974981 PMC3101474 NIHMS293685
31: Liu SV, Douer D
Reply.
Acta Haematol 126: 240 (2011)
PM ID: 21952727
32: Choi SH, Heo K, Byun HM, An W, Lu W, Yang AS
Identification of preferential target sites for human DNA methyltransferases.
Nucleic Acids Res 39: 104-18 (2011)
PM ID: 20841325 PMC3017615
33: Thai M, Ting PY, McLaughlin J, Cheng D, Müschen M, Witte ON, Colicelli J
ABL fusion oncogene transformation and inhibitor sensitivity are mediated by the cellular regulator RIN1.
Leukemia 25: 290-300 (2011)
PM ID: 21102429 PMC3049868
34: Stanford SM, Krishnamurthy D, Falk MD, Messina R, Debnath B, Li S, Liu T, Kazemi R, Dahl R, He Y, Yu X, Chan AC, Zhang ZY, Barrios AM, Woods VL, Neamati N, Bottini N
Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cells.
J Med Chem 54: 1640-54 (2011)
PM ID: 21341673 PMC3086468 NIHMS276264
35: Duy C, Hurtz C, Shojaee S, Cerchietti L, Geng H, Swaminathan S, Klemm L, Kweon SM, Nahar R, Braig M, Park E, Kim YM, Hofmann WK, Herzog S, Jumaa H, Koeffler HP, Yu JJ, Heisterkamp N, Graeber TG, Wu H, Ye BH, Melnick A, Müschen M
BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition.
Nature 473: 384-8 (2011)
PM ID: 21593872 PMC3597744 NIHMS268753
36: Park E, Gang EJ, Hsieh YT, Schaefer P, Chae S, Klemm L, Huantes S, Loh M, Conway EM, Kang ES, Hoe Koo H, Hofmann WK, Heisterkamp N, Pelus L, Keerthivasan G, Crispino J, Kahn M, Müschen M, Kim YM
Targeting survivin overcomes drug resistance in acute lymphoblastic leukemia.
Blood 118: 2191-9 (2011)
PM ID: 21715311 PMC3162353
37: Jiang XX, Nguyen Q, Chou Y, Wang T, Nandakumar V, Yates P, Jones L, Wang L, Won H, Lee HR, Jung JU, Müschen M, Huang XF, Chen SY
Control of B cell development by the histone H2A deubiquitinase MYSM1.
Immunity 35: 883-96 (2011)
PM ID: 22169041
38: Liu HM, Aizaki H, Machida K, Ou JH, Lai MM
Hepatitis C virus translation preferentially depends on active RNA replication.
PLoS One 7: e43600 (2012)
PM ID: 22937067 PMC3427374
39: Cozen W, Li D, Best T, Van Den Berg DJ, Gourraud PA, Cortessis VK, Skol AD, Mack TM, Glaser SL, Weiss LM, Nathwani BN, Bhatia S, Schumacher FR, Edlund CK, Hwang AE, Slager SL, Fredericksen ZS, Strong LC, Habermann TM, Link BK, Cerhan JR, Robison LL, Conti DV, Onel K
A genome-wide meta-analysis of nodular sclerosing Hodgkin lymphoma identifies risk loci at 6p21.32.
Blood 119: 469-75 (2012)
PM ID: 22086417 PMC3257012
40: Levine AM, Noy A, Lee JY, Tam W, Ramos JC, Henry DH, Parekh S, Reid EG, Mitsuyasu R, Cooley T, Dezube BJ, Ratner L, Cesarman E, Tulpule A
Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047.
J Clin Oncol 31: 58-64 (2013)
PM ID: 23169503 PMC3530691
41: Cui X, Lu Z, Kurosawa A, Klemm L, Bagshaw AT, Tsai AG, Gemmell N, Müschen M, Adachi N, Hsieh CL, Lieber MR
Both CpG methylation and activation-induced deaminase are required for the fragility of the human bcl-2 major breakpoint region: implications for the timing of the breaks in the t(14;18) translocation.
Mol Cell Biol 33: 947-57 (2013)
PM ID: 23263985 PMC3623081
42: Hsieh YT, Gang EJ, Geng H, Park E, Huantes S, Chudziak D, Dauber K, Schaefer P, Scharman C, Shimada H, Shojaee S, Klemm L, Parameswaran R, Loh M, Kang ES, Koo HH, Hofmann WK, Andrade J, Crooks GM, Willman CL, Müschen M, Papayannopoulou T, Heisterkamp N, Bönig H, Kim YM
Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy.
Blood 121: 1814-8 (2013)
PM ID: 23319569 PMC3591800
43: Parameswaran R, Lim M, Arutyunyan A, Abdel-Azim H, Hurtz C, Lau K, Müschen M, Yu RK, von Itzstein M, Heisterkamp N, Groffen J
O-acetylated N-acetylneuraminic acid as a novel target for therapy in human pre-B acute lymphoblastic leukemia.
J Exp Med 210: 805-19 (2013)
PM ID: 23478187 PMC3620349
44: Parekh C, Crooks GM
Critical differences in hematopoiesis and lymphoid development between humans and mice.
J Clin Immunol 33: 711-5 (2013)
PM ID: 23274800 PMC3633618 NIHMS432026
45: Mbulaiteye SM, Pullarkat ST, Nathwani BN, Weiss LM, Rao N, Emmanuel B, Lynch CF, Hernandez B, Neppalli V, Hawes D, Cockburn MG, Kim A, Williams M, Altekruse S, Bhatia K, Goodman MT, Cozen W
Epstein-Barr virus patterns in US Burkitt lymphoma tumors from the SEER residual tissue repository during 1979-2009.
APMIS 122: 5-15 (2014)
PM ID: 23607450 PMC3723754 NIHMS453148
46: Gang EJ, Hsieh YT, Pham J, Zhao Y, Nguyen C, Huantes S, Park E, Naing K, Klemm L, Swaminathan S, Conway EM, Pelus LM, Crispino J, Mullighan CG, McMillan M, Müschen M, Kahn M, Kim YM
Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia.
Oncogene 33: 2169-78 (2014)
PM ID: 23728349 PMC3994178 NIHMS560207